Los Angeles Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-141
Closed -$5.38K – 2335
2026
Q1
$5.38K Hold
141
– – ﹤0.01% 2111
2025
Q4
$2.76K Buy
+141
New +$2.93K ﹤0.01% 2388
2025
Q3
– Sell
-20,096
Closed -$515K – 1367
2025
Q2
$515K Buy
20,096
+13,212
+192% +$387K ﹤0.01% 850
2025
Q1
$252K Sell
6,884
-2,636
-28% -$90.7K ﹤0.01% 946
2024
Q4
$292K Sell
9,520
-280
-3% -$9.31K ﹤0.01% 938
2024
Q3
$369K Buy
9,800
+2,009
+26% +$77.4K ﹤0.01% 945
2024
Q2
$308K Sell
7,791
-1,200
-13% -$38.8K ﹤0.01% 1001
2024
Q1
$302K Buy
+8,991
New +$302K ﹤0.01% 1001
2023
Q3
– Sell
-8,211
Closed -$260K – 1119
2023
Q2
$260K Buy
+8,211
New +$265K ﹤0.01% 1048

Other funds holding ATEX

Los Angeles Capital Management's ATEX Position: Q2 2026 in Review

Los Angeles Capital Management sold out of Anterix (ATEX) in Q2 2026, closing a stake of 141 shares — an estimated $5.38K sold.

Los Angeles Capital Management first reported a position in ATEX in Q2 2023 and held it in 9 quarters. The position peaked at $515K in Q2 2025. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Los Angeles Capital Management reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 141 Anterix shares in Q2 2026, an estimated $5.38K.
  • Los Angeles Capital Management first reported a position in Anterix in Q2 2023 and held it in 9 quarters.
  • Los Angeles Capital Management's Anterix position peaked at $515K in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.